Skip to main navigation
Skip to search
Skip to main content
Universitas Indonesia Home
Home
Profiles
Research units
Research output
Equipments
Projects
Activities
Press/Media
Search by expertise, name or affiliation
Curcumin as Adjuvant Therapy in COVID-19: Friend or Foe?
Jeanne Adiwinata Pawitan
Department of Histology Pre Clinic
Research output
:
Contribution to journal
›
Article
›
peer-review
11
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Curcumin as Adjuvant Therapy in COVID-19: Friend or Foe?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Curcumin
100%
Adjuvant Therapy
100%
COVID-19
100%
Angiotensin-converting Enzyme 2 (ACE2)
33%
Herbal Drinks
33%
Viral Entry
22%
Cytokine Storm
22%
Viral
11%
Antioxidant Properties
11%
Myocardial Fibrosis
11%
Rat Model
11%
Beneficial Effects
11%
High Dose
11%
Optimal Dose
11%
Severe Disease
11%
In Silico Study
11%
Immune Response
11%
Anti-inflammatory Properties
11%
Effective Compounds
11%
Antimicrobial Properties
11%
Severe COVID-19
11%
Optimal Timing
11%
Timing of Administration
11%
Antiviral Properties
11%
S1 Protein
11%
SARS-CoV-2 Entry
11%
Pharmacology, Toxicology and Pharmaceutical Science
Curcumin
100%
SARS Coronavirus
22%
Cytokine Storm
22%
Receptor
11%
Antioxidant
11%
Antiinfective Agent
11%
Antivirus Agent
11%
Anti-Inflammatory Drug
11%
Heart Muscle Fibrosis
11%
Rat Model
11%